NIVABUPAFinancial Services

Niva Bupa Health Insurance Company Limited

General Insurance · ISIN INE995S01015 · BSE 544286 · NSE EQ · FV ₹10
Last price
₹80
+0.06%today
What this company does

Niva Bupa Health Insurance Company Limited operates in General Insurance, part of the Financial Services sector.

In the report:
Equitytale Health Score
Insufficient data

We could measure only 15% of what this score needs, so we are not publishing a number for this company. What we could measure is below.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
38

At close. Not part of the score.

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: profitability & returns, balance sheet, cash quality, growth & consistency, valuation. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
A mixed picture
Strengths
Promoters hold 55%
No promoter shares pledged
Watch-outs
! Operating cash flow is negative

What if I invest in NIVABUPA?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹80 +0.06%
latest close · 2026-09-17
52-wk low ₹7842 sessions so far52-wk high ₹91
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.13Comfortable
LowModerateHigh ▸1
Current ratio0.34Tight
Tight ◂1HealthyAmple
More figures
Market cap
Book value
EPS
latest quarter
Net debt
Enterprise value
EBITDA
EBIT
Operating margin
Return on assets
Earnings yield
P/S
Sales / share
Tax rate
Face value
₹10
Working capital
₹-2,880 cr
Current assets
₹1,484 cr
Current liabilities
₹4,363 cr
Delivery %
54.9%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Hard to value confidentlyLow confidence
We haven't parsed this company's annual profit history yet — common for banks and insurers, whose results file in a different format — so we can't value it off earnings.

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q4 FY26 (consolidated)
Other Income₹-25 cr
Where the money goes

Not enough income-statement detail filed to break this down yet.

Quarterly results · consolidated (₹ cr)
MetricQ2 FY26Q3 FY26Q4 FY26
Revenue
Total income
Expenses
Profit before tax
Tax
Net profit (owners' share)
Net margin (owners' share, on revenue)
EPS (₹)
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹3,452 cr
Shareholder equity
₹1,959 cr
parent shareholders
Total debt
₹250 cr
Cash
Cash flow · H1 FY26
Operating
₹-123 cr
Investing
₹-29 cr
Financing
₹19 cr
Peer comparison
General Insurance · by market value
CompanyPriceMarket capP/E
General Insurance Corporation of India₹340
The New India Assurance Company Limited₹197
Niva Bupa Health Insurance Company Limitedthis company₹80
Go Digit General Insurance Limited₹256
Star Health and Allied Insurance Company Limited₹561
ICICI Lombard General Insurance Company Limited₹1,487
Same industry · latest reported numbers · not a recommendation.
Who owns it · 2026-06-30
No pledge
Promoter
55.3%
FII / Foreign
12.1%
DII / Domestic
16.2%
Retail / others
16.4%
Promoter stake down 0.7% over the last 8 quarters.
Smart-money activity
Insider trades
SoldVikas Gupta · -40,000 · ₹32.3 L26 Dec 24
SoldKrishnan Ramachandran · Key Managerial Personnel50.00 L · ₹41.8 cr12 Dec 24
SoldBhabatosh Mishra · -25,000 · ₹22.9 L9 Dec 24
Bulk / block deals
short · NSE853 Sep 26
short · NSE87 May 26
short · NSE42418 Mar 26
Stake changes
BoughtAranda Investments Pte Ltd→ 5.00% · 70,0005 Feb 26
SoldFettle Tone LLP→ 8.00% · 17.29 cr2 Jun 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 12 Aug 2026
See the official result
1
To receive, consider and adopt the Audited Financial Statements comprising the Balance Sheet, Profit & Loss Account, Revenue Account, Receipts & Payments Account of the Company together with the Notes to Financial Statements, report of Board of Directors and Auditor’s thereon for the Financial Year ended March 31, 2026
Backed by 100% of shareholders other than promotersneeded 50%
68.79 cr votes for, 1,900 against · 0% of mutual funds and other big investors said no
2
To appoint Mr. Vishwanath Mahendra (DIN: 11019011), who retires by rotation and being eligible, offers himself for re-appointment
Backed by 100% of shareholders other than promotersneeded 50%
68.26 cr votes for, 20.33 L against · 0% of mutual funds and other big investors said no
3
To appoint Mr. Ankur Kharbanda (DIN: 11019017), who retires by rotation and being eligible, offers himself for re-appointment
Backed by 100% of shareholders other than promotersneeded 50%
68.58 cr votes for, 20.33 L against · 0% of mutual funds and other big investors said no
4
To approve the audit remuneration of M/s. S.R. Batliboi & Co. LLP, Chartered Accountants, Joint Statutory Auditors for the Financial Year 2026-27
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
68.79 cr votes for, 4,960 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 144 named members
owning 55.3% between them · as of 2026-06-30
Bupa Singapore Holdings Pte Ltd55.30%
4DENT Sp. z.o.o.no shares
A2 Clinic Sp. z.o.o.no shares
Advanced Skincare S.L.no shares
Amedex Services Ltd. (St Kitts)no shares
Anglolab S. Ano shares
Benefit Pocket Pty Ltdno shares
Bupa Administracion y Servicios SpAno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹800 cr raised in Nov 2024 by selling shares to the public

As of Sep 2025, the company says it has spent 100% of what it set aside.

Augmentation of capital base to maintain and strengthen solvency levels
100%
₹800 cr of ₹800 cr
Spent by quarter: 99%99%100% (to Sep 2025)

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.